Intrinsic Value

Vivoryon Therapeutics N.V. (VVY.AS)

0.71 €

+0.06 (+9.57%)

Enterprise Value -
Net Debt -26.42
Equity Value -
Shares Outstanding 22.02
Equity Value Per Share -



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt